Table 6.

The clinical summary of Rubicz et al.’s cohort [31] used for the cross-validation of the primary findings.

	n = 503
Age group (years)
35–49	67
50–54	90
55–59	123
60–64	145
65–69	53
70–74	25
Preoperative PSA for EAU BCR risk groups
<10 ng/mL	369
10–20 ng/mL	72
>20 ng/mL	29
NA	33
Stage
Local	338
Regional	165
Gleason score
6	239
7A (3 + 4)	184
7B (4 + 3)	40
8–10	40